Clinical Takeaway CBD at low doses administered short-term did not significantly improve glucose tolerance or alter gut microbiome composition in sedentary overweight or obese adults, despite theoretical mechanisms suggesting potential benefit. This...
Cannabidiol Glucose Tolerance Effects in Obesity
Clinical Takeaway Clinical Takeaway: In this pilot study of overweight and sedentary adults, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance or alter the gut microbiome composition compared...
Endocannabinoid System Research: CBD and Glucose
Clinical Takeaway Clinical Takeaway In sedentary adults with overweight or obesity, short-term low-dose CBD treatment did not produce measurable improvements in glucose tolerance or alterations to gut microbiome composition. These pilot findings...
Changes in levels of endocannabinoidome mediators in mice with cancer cachexia: links with steatosis and gut microbial dysbiosis.
Cachexia is a debilitating syndrome associated with involuntary weight loss, often occurring in cancer patients. In both humans and animal models, alteration…
Cannabidiol & Glucose Tolerance: Clinical Research Findings
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, alter gut microbiome composition, or reduce inflammation in sedentary adults with overweight or obesity. While animal research...
Research Digest: 20 Recent Studies – March 18, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...
endocannabinoid system clinical research: CBD & Metabolic Health
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not improve glucose tolerance or meaningfully alter gut microbiome composition in sedentary adults with overweight or obesity. While epidemiological data suggest...